| ∧ ∨ Type | ∧ ∨ Title | Principal Investigators | Status | ∧ ∨ Year |
|---|---|---|---|---|
| FON_NAZ - Bandi Altre Fondazioni |
Basi molecolari per lo sviluppo di strategie chemiopreventive e terapeutiche innovative nel melanoma: recettore estrogenico beta, epigenetica e tocotrienoli
|
|
Closed | 2015 |
| FON_NAZ - Bandi Altre Fondazioni |
Translating molecular pathology into a therapeutic strategy in SCA38, a newly identified form of spinocerebellar ataxia
|
|
Closed | 2014 |
| FON_NAZ - Bandi Altre Fondazioni |
Patent development of new modulators of GPR17, a key receptor in remyelinating processes
|
|
Closed | 2015 |
| FON_NAZ - Bandi Altre Fondazioni |
Developmental exposure to cocaine as a risk factor for adolescent depression: unraveling the underlying molecular mechanisms in preclinical models
|
|
Closed | 2014 |
| FON_NAZ - Bandi Altre Fondazioni |
Upregulation of HSPB8 as potential therapeutic approach in familial and sporadic ALS
|
|
Closed | 2012 |
| FON_NAZ - Bandi Altre Fondazioni |
Naturally gluten free pigmented cereals to modulate the inflammatory status in CD
|
|
Closed | 2020 |
| FON_NAZ - Bandi Altre Fondazioni |
Engineered T regulatory cells to control the immune-inflammatory response and the accelerated onset of atherosclerosis in familial hypercholesterolemia
|
|
Closed | 2013 |
| FON_NAZ - Bandi Altre Fondazioni |
Semaphorin3E and CHD7 signalling pathways in the control of olfaction and reproduction: link for Kallmann and Charge syndromes?
|
|
Closed | 2013 |
| FON_NAZ - Bandi Altre Fondazioni |
Patent development of new modulators of GPR17, a key receptor in remyelinating processes
|
|
Closed | 2013 |
| FON_NAZ - Bandi Altre Fondazioni |
Basi molecolari per lo sviluppo di strategie chemiopreventive e terapeutiche innovative nel melanoma: recettore estrogenico beta, epigenetica e tocotrienoli
|
|
Closed | 2012 |
